FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

736837006: Glecaprevir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3525352016 Glecaprevir (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3525353014 Glecaprevir en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glecaprevir Is a Sulfonamide true Inferred relationship Existential restriction modifier
Glecaprevir Is a Quinoxaline true Inferred relationship Existential restriction modifier
Glecaprevir Has disposition Hepatitis C virus NS3/4A protease inhibitor true Inferred relationship Existential restriction modifier
Glecaprevir Is a Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing glecaprevir and pibrentasvir Has active ingredient True Glecaprevir Inferred relationship Existential restriction modifier 2
Product containing glecaprevir and pibrentasvir in oral dose form (medicinal product form) Has active ingredient True Glecaprevir Inferred relationship Existential restriction modifier 2
Glecaprevir + Pibrentasvir Has active ingredient True Glecaprevir Inferred relationship Existential restriction modifier 2
Product containing only glecaprevir and pibrentasvir in oral dose form (medicinal product form) Has active ingredient True Glecaprevir Inferred relationship Existential restriction modifier 2
Product containing glecaprevir (medicinal product) Has active ingredient True Glecaprevir Inferred relationship Existential restriction modifier 1
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Glecaprevir Inferred relationship Existential restriction modifier 2
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Glecaprevir Inferred relationship Existential restriction modifier 2
Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free 28 sachet Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Maviret 50mg/20mg granules sachets (AbbVie Ltd) 28 sachet Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Maviret 50mg/20mg granules sachets (AbbVie Ltd) Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets 84 tablet Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) 84 tablet 4 x 21 tablets Has specific active ingredient True Glecaprevir Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start